Detalles de la búsqueda
1.
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.
Lancet Oncol
; 20(10): 1370-1385, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31427204
2.
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.
Br J Cancer
; 120(12): 1113-1119, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31105270
3.
TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma.
Cancer Immunol Immunother
; 68(9): 1493-1500, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31501955
4.
Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
World J Surg Oncol
; 15(1): 193, 2017 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29096642
5.
Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial.
J Transl Med
; 14: 12, 2016 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-26762579
6.
MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Mol Cancer
; 14: 68, 2015 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25889255
7.
Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxel.
Prostate
; 74(4): 433-40, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24338986
8.
A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer.
Prostate
; 74(15): 1544-50, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25175831
9.
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone.
Prostate
; 74(14): 1462-4, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25111736
10.
Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio.
Cancer
; 120(21): 3346-52, 2014 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24995769
11.
Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.
Mol Cancer
; 11: 44, 2012 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-22747855
12.
The Utility of 68Ga-PSMA PET/CT in Decisions Regarding Administering Salvage Radiotherapy to Men with Prostate Cancer.
Int J Environ Res Public Health
; 20(1)2022 12 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36612859
13.
Checkpoint Genes at the Cancer Side of the Immunological Synapse in Bladder Cancer.
Transl Oncol
; 13(2): 193-200, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31869744
14.
Isolated autoimmune adrenocorticotropic hormone deficiency: From a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors.
Autoimmun Rev
; 19(2): 102454, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838158
15.
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial.
J Immunother Cancer
; 8(2)2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32661118
16.
Accelerated Hypofractionated Radiation Therapy for Elderly Frail Bladder Cancer Patients Unfit for Surgery or Chemotherapy.
Am J Clin Oncol
; 42(2): 179-183, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30451730
17.
Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study.
Eur J Cancer
; 120: 122-131, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31518968
18.
High-Throughput Architecture for Discovering Combination Cancer Therapeutics.
JCO Clin Cancer Inform
; 2: 1-12, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30652536
19.
The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study.
Bladder Cancer
; 4(2): 185-194, 2018 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29732389
20.
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
Radiat Oncol
; 12(1): 5, 2017 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28061904